Access

Letters to Nature

Nature 407, 1029-1034 (26 October 2000) | doi:10.1038/35039551; Received 10 April 2000; Accepted 15 September 2000

Open Innovation Challenges

Crystal structure of fibroblast growth factor receptor ectodomain bound to ligand and heparin

Luca Pellegrini1, David F. Burke1, Frank von Delft1, Barbara Mulloy2 & Tom L. Blundell1

  1. Department of Biochemistry, University of Cambridge, 80 Tennis Court Road, Cambridge , CB2 1GA, UK
  2. National Institute for Biological Standards and Control, South Mimms, Potters Bar, EN6 3QG, UK

Correspondence to: Tom L. Blundell1 Correspondence and requests for materials should be addressed to L.P (e-mail: Email: luca@cryst.bioc.cam.ac.uk) or T.L.B. (e-mail: Email:  tom@cryst.bioc.cam.ac.uk). Coordinates have been deposited in the Protein Data Bank with accession number 1e0o.

Top

Fibroblast growth factors (FGFs) are a large family of structurally related proteins with a wide range of physiological and pathological activities1. Signal transduction requires association of FGF with its receptor tyrosine kinase (FGFR)2 and heparan sulphate proteoglycan in a specific complex on the cell surface. Direct involvement of the heparan sulphate glycosaminoglycan polysaccharide in the molecular association between FGF and its receptor is essential for biological activity3, 4, 5. Although crystal structures of binary complexes of FGF–heparin6, 7 and FGF–FGFR8, 9 have been described, the molecular architecture of the FGF signalling complex has not been elucidated. Here we report the crystal structure of the FGFR2 ectodomain in a dimeric form that is induced by simultaneous binding to FGF1 and a heparin decasaccharide. The complex is assembled around a central heparin molecule linking two FGF1 ligands into a dimer that bridges between two receptor chains. The asymmetric heparin binding involves contacts with both FGF1 molecules but only one receptor chain. The structure of the FGF1–FGFR2–heparin ternary complex provides a structural basis for the essential role of heparan sulphate in FGF signalling.